FR2430228A1 - Medicament contre les maladies de la peau - Google Patents
Medicament contre les maladies de la peauInfo
- Publication number
- FR2430228A1 FR2430228A1 FR7812906A FR7812906A FR2430228A1 FR 2430228 A1 FR2430228 A1 FR 2430228A1 FR 7812906 A FR7812906 A FR 7812906A FR 7812906 A FR7812906 A FR 7812906A FR 2430228 A1 FR2430228 A1 FR 2430228A1
- Authority
- FR
- France
- Prior art keywords
- skin disease
- disease medicine
- skin
- compositions
- mepacrine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
Abstract
L'invention concerne un médicament contre les maladies de la peau. Elle couvre des compositions pharmaceutiques administrées aux hommes et aux animaux par voie topique comprenant un excipient pharmaceutique avec au moins un ingrédient actif choisi dans le groupe comprenant le bromure de parabromophénacyle, l' alpha -tocophérol, la mépacrine, la chloroquine, l'hydroxychloroquine, la dibucaine, la tétracaine, la lidocaïne, la butacaïne, la procaïne,l'acide éthylènediaminetétracétique et l'acide éthylèneglycol-bis - ( beta -aminoéthyléther) - N,N'-tétraacétique ; ces compositions peuvent également contenir un ou plusieurs composés aliphatiques insaturés, un glucocorticoïde et une prostaglandine. Ces médicaments conviennent en particulier pour lutter contre le psoriasis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/793,100 US4181725A (en) | 1977-05-02 | 1977-05-02 | Method for alleviating psoriasis |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2430228A1 true FR2430228A1 (fr) | 1980-02-01 |
Family
ID=25159088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7812906A Withdrawn FR2430228A1 (fr) | 1977-05-02 | 1978-05-02 | Medicament contre les maladies de la peau |
Country Status (6)
Country | Link |
---|---|
US (1) | US4181725A (fr) |
JP (1) | JPS53136521A (fr) |
AU (1) | AU3543378A (fr) |
BE (1) | BE866611A (fr) |
DE (1) | DE2818553A1 (fr) |
FR (1) | FR2430228A1 (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5659710A (en) * | 1979-10-22 | 1981-05-23 | Eisai Co Ltd | Preventive and remedy for psoriasis |
IE51145B1 (en) * | 1980-03-07 | 1986-10-15 | Efamol Ltd | Pharmaceutical and dietary compositions |
US4451482A (en) * | 1982-04-22 | 1984-05-29 | Shell Oil Company | Method of preventing or ameliorating pyrethroid skin sensory stimulation |
US4788061A (en) * | 1985-07-05 | 1988-11-29 | Shore Ronald N | Extended occlusive treatment of skin disorders |
US5002974A (en) * | 1988-04-04 | 1991-03-26 | Warner-Lambert Co. | Anesthetic/skin moisturizing composition and method of preparing same |
US4861783A (en) * | 1988-04-26 | 1989-08-29 | E. I. Du Pont De Nemours And Company | 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases |
SE8804214L (sv) * | 1988-11-22 | 1990-05-23 | Jean Cassuto | Antiinflammatoriskt och antiinfektioest medikament |
US4908162A (en) * | 1988-11-22 | 1990-03-13 | David Rubin | Method of making triple bonded unsaturated fatty acids |
FR2664164A1 (fr) * | 1990-07-04 | 1992-01-10 | Texinfine Patrinove | Composition dermatologique ou cosmetique. |
GB9101986D0 (en) * | 1991-01-30 | 1991-03-13 | Smith & Nephew | Pharmaceutical compositions |
JPH06506014A (ja) * | 1991-03-20 | 1994-07-07 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 放射線硬化性ビニル/シリコーン剥離コーティング |
US5324746A (en) * | 1993-02-12 | 1994-06-28 | Mckee Rex N | Method of treating damaged mucosal and epithelial tissues with misoprostol |
CA2130291A1 (fr) * | 1993-08-18 | 1995-02-19 | Juan Carlos Mahiques | Utilisation therapeutique des composes connus de types ester et amide |
US5478837A (en) * | 1994-06-07 | 1995-12-26 | University Of Southern California | Use of quinacrine in preventing adhesion formation |
US6176240B1 (en) * | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US6705323B1 (en) | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
WO1998017231A2 (fr) * | 1996-10-18 | 1998-04-30 | Charous B Lauren | Traitement et administration d'hydroxychloroquine |
US6153197A (en) * | 1996-12-18 | 2000-11-28 | Albazi; Rakhi | Topical treatment of psoriasis |
US5994399A (en) * | 1997-03-27 | 1999-11-30 | Mckee; Rex N. | Method of regenerating collagen-containing tissues with misoprostol |
US5935137A (en) * | 1997-07-18 | 1999-08-10 | Gynecare, Inc. | Tubular fallopian sterilization device |
US6703384B2 (en) * | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
WO2000066107A2 (fr) * | 1999-04-30 | 2000-11-09 | Apt Pharmaceuticals, L.L.C. | Nouvelles applications d'agents therapeutiques antipaludeens |
WO2001028550A1 (fr) * | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | Anesthesiques topiques employes dans le traitement du cancer, les affections auto-immunes et l'ischemie |
US10179159B2 (en) * | 1999-10-22 | 2019-01-15 | Scott Wepfer | Topical anesthetic formulation |
US20020046357A1 (en) * | 1999-12-28 | 2002-04-18 | Jiandong Huang | Software-based fault tolerant networking using a single LAN |
CA2399802C (fr) * | 2000-02-11 | 2009-12-08 | Research Development Foundation | Tocopherols, tocotrienols, autres derives a chaines chromane et laterales et utilisations de ces derniers |
CA2466338C (fr) * | 2001-11-09 | 2010-01-12 | Lauren Charous | Nouvelles utilisations pour des agents therapeutiques antipaludiques |
NZ532836A (en) * | 2001-11-09 | 2005-11-25 | Lauren Charous | A method for treating inflammatory bowel disease |
US20040220220A1 (en) * | 2001-11-09 | 2004-11-04 | Charous B. Lauren | Method for treating inflammatory bowel disease |
US20040214860A1 (en) * | 2001-11-09 | 2004-10-28 | Charous B. Lauren | Method for treating inflammatory bowel disease |
US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
CN100515497C (zh) * | 2001-12-19 | 2009-07-22 | 研究发展基金会 | 脂质体输送以维生素e为基础的化合物 |
US20050159485A1 (en) * | 2002-01-04 | 2005-07-21 | Jost-Price Edward R. | Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases |
WO2003092617A2 (fr) * | 2002-05-03 | 2003-11-13 | Combinatorx, Incorporated | Combinaisons destinees au traitement de troubles cutanes inflammatoires |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
US7108992B2 (en) * | 2002-11-27 | 2006-09-19 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
US6916627B2 (en) * | 2002-11-27 | 2005-07-12 | St. Jude Children's Research Hospital | ATM kinase compositions and methods |
US7241746B2 (en) * | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
DE102004059613A1 (de) * | 2004-12-10 | 2006-06-14 | Liedtke, Rainer K., Dr. | Zusammensetzung und Methode einer topischen Therapie von Neurodermitis |
US20070023534A1 (en) * | 2005-07-22 | 2007-02-01 | Mingsheng Liu | Water-source heat pump control system and method |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
EP3317274A4 (fr) * | 2015-06-30 | 2019-05-08 | Eiger Group International, Inc. | Utilisation de composés de chloroquine et de clémizole pour le traitement d'états pathologiques inflammatoires et cancéreux |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB859897A (en) * | 1958-07-05 | 1961-01-25 | Roche Products Ltd | Novel unsaturated acids and esters thereof and a process for the manufacture and conversion of same |
US3450821A (en) * | 1967-03-02 | 1969-06-17 | Hoffmann La Roche | Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof |
BE754114A (fr) * | 1969-07-29 | 1971-01-29 | Upjohn Co | Nouveaux composes de la classe des prostaglandines et leur procede de preparation |
US3903297A (en) * | 1973-11-01 | 1975-09-02 | Upjohn Co | Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs |
-
1977
- 1977-05-02 US US05/793,100 patent/US4181725A/en not_active Expired - Lifetime
-
1978
- 1978-04-26 AU AU35433/78A patent/AU3543378A/en active Pending
- 1978-04-27 DE DE19782818553 patent/DE2818553A1/de active Pending
- 1978-05-02 JP JP5329178A patent/JPS53136521A/ja active Pending
- 1978-05-02 BE BE187311A patent/BE866611A/fr unknown
- 1978-05-02 FR FR7812906A patent/FR2430228A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE2818553A1 (de) | 1978-11-09 |
US4181725A (en) | 1980-01-01 |
BE866611A (fr) | 1978-09-01 |
JPS53136521A (en) | 1978-11-29 |
AU3543378A (en) | 1979-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2430228A1 (fr) | Medicament contre les maladies de la peau | |
CA2191129A1 (fr) | Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine | |
EP0362270B1 (fr) | Lotion pour application de steroides | |
FR2362833A1 (fr) | Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant | |
MA27156A1 (fr) | NUCLEOSIDES 3- β-D-RIBOFURANOSYLTHIAZOLO[4,5-d] PYRIDIMINE ET LES UTILISATIONS DE CELLES-CI | |
TNSN97091A1 (fr) | CONJUGUE PEG-IFN α PHYSIOLOGIQUEMENT ACTIF, PROCEDE POUR SA PREPARATION, COMPOSITIONS PHARMACEUTIQUES LE CONTENANT ET LEUR UTILISATION | |
FR2356424A1 (fr) | Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales | |
DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
WO1995018622A1 (fr) | Agents de chimioprevention ou de chimiotherapie du cancer du colon a base de derives de l'acide 2-hydroxy-5-phenylazobenzoique | |
CA2231342A1 (fr) | Composition pharmaceutique pour administration par voie orale | |
SE8001599L (sv) | Transdermalt medicineringssystem for isosorbiddinitrat | |
BE900564A (fr) | Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. | |
BE906034A (fr) | Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques | |
FR2554346B1 (fr) | Ensemble et procede pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques les contenant | |
IE43693L (en) | Androstane derivatives | |
FR2393577A1 (fr) | Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse | |
FR2422640A1 (fr) | Nouvelles morphinane-6-ones a substituant 8b-alkyle, leur procede de production et medicament les contenant | |
FR2405067A1 (fr) | Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees | |
FR2420344A1 (fr) | Nouveaux oxime-ethers, leur preparation et leur application therapeutique. | |
FR2393579A1 (fr) | Agent antiviral et son application au traitement des affections virales | |
FR2404010A1 (fr) | Nouveaux derives de pyrimido-(2,1-a)isoquinoleine, leur procede de production et composition pharmaceutique les contenant | |
FR2362587A1 (fr) | Agents antimicrobie | |
FR2507605B1 (fr) | Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters | |
FR2391191A1 (fr) | Nouveaux composes polypeptidiques, lyeptidiques, leur preparation et leur application comme medicaments | |
RU2005122466A (ru) | Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |